Selank
N-[(3S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]propanoyl]pyrrolidin-2-yl]formyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-1H-imidazole-4-carboxamide
Selank is a synthetic anxiolytic peptide that selectively modulates GABA and serotonin neurotransmitter systems while enhancing BDNF expression. It provides anxiolytic effects without sedation, making it ideal for cognitive enhancement and stress management applications.
Complete Research Database
Adverse Event Frequencies (Clinical Trials)
Clinical Safety Notes
- •GI side effects typically occur during dose escalation
- •Most adverse events are mild to moderate in severity
- •Discontinuation rate due to side effects: ~5.3%
- •No increased risk of pancreatitis in clinical trials
- •Regular monitoring recommended for thyroid function
Medical Disclaimer
This information is for educational purposes only and is not intended as medical advice. Selank is a research compound and should only be used under qualified medical supervision. Consult with a healthcare provider familiar with peptide therapies before considering use. Individual results may vary significantly.